Phlexglobal, a PharmaLex company, is the recognized global authority in Trial Master File (TMF) services and technology. Hundreds of sponsor and CRO companies worldwide rely on Phlexglobal’s next-generation eTMF solution and more than 150 experts to elevate TMF management, reduce inspection risk, and solve TMF challenges. Our extensive TMF expertise meets innovation in everything we do, from PhlexTMF – the industry’s first AI-powered eTMF that reduces document misfiles and metadata errors from day one – to expert quality review and embedded study owners to support busy study teams, letting you achieve the highest standards for TMF completeness, timeliness, and quality.
In 2024 and beyond Phlexglobal and all the companies in the PharmaLex family will begin a journey to becoming Cencora as well. It’s a name that represents a global focus on empowering our partners with transformative solutions for broader equity, sustainability and impact in healthcare. Read More